Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573595 · ClinicalTrials.gov registry record · NA
Fresenius Noninvasive Blood Pressure Validation
A NA study of Blood Pressure, sponsored by Fresenius Medical Care North America.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
- 1
- Study location
NCT04573595: Completed NA study of Blood Pressure, sponsored by Fresenius Medical Care North America.
NCT04573595 is a NA study of Blood Pressure that has completed, run by Fresenius Medical Care North America. The registered enrollment target is 159 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04573595, a NA study of Blood Pressure, has completed, sponsored by Fresenius Medical Care North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study to collect blood pressure measurement values from the blood pressure measurement device on the Fresenius machine as compared to the standard method.
Primary Outcome
The Fresenius 5008S BPM with cuffs will be compared to the Reference sphygmomanometer via dual auscultator method. This will be a one-time measurement only no patient follow-up will be performed.
Conditions Studied
Interventions
- DEVICE Blood Pressure Measurement
Study Locations (1)
Colorado
- Clinimark, Site ID#001 - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2020-09-17 |
| Est. Completion | 2020-12-04 |
| Phase | NA |
What the finished NCT04573595 record still lists
NCT04573595 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Blood Pressure Measurement is the first listed.
NCT04573595 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04573595 about?
NCT04573595 is a clinical study titled "Fresenius Noninvasive Blood Pressure Validation". The purpose of this study to collect blood pressure measurement values from the blood pressure measurement device on the Fresenius machine as compared to the standard method.
What is the current status of trial NCT04573595?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2020-09-17. Estimated completion is 2020-12-04.
What conditions does trial NCT04573595 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT04573595?
The interventions under investigation include: Blood Pressure Measurement (DEVICE).
Who is sponsoring clinical trial NCT04573595?
This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04573595 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04573595's enrollment target sits among peer trials
159 27th of 101 higher than 75 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI